Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection
NCT ID: NCT06377462
Last Updated: 2025-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2024-03-13
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Efficacy and Safety of VX-814 in Subjects With the PiZZ Genotype
NCT04167345
Mucopolysaccharidosis VII Disease Monitoring Program
NCT03604835
A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I
NCT06926621
Pompe Disease Registry Protocol
NCT00231400
The Global Angelman Syndrome Registry
NCT05293184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years
* Signed informed consent form
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bristol-Myers Squibb
INDUSTRY
University Hospital Munich
OTHER
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katja Sockel, Dr. med.
Role: STUDY_CHAIR
TU Dresden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Aachen
Aachen, , Germany
Klinikum Chemnitz gGmbH
Chemnitz, , Germany
Universitätsklinikum Carl Gustav Carus
Dresden, , Germany
Universitätsklinikum Düsseldorf
Düsseldorf, , Germany
Evang. Kliniken Essen-Mitte
Essen, , Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, , Germany
Universitätsklinikum Leipzig AöR
Leipzig, , Germany
Universitätsmedizin Mannheim
Mannheim, , Germany
Klinikum rechts der Isar TUM
München, , Germany
Klinikum Osnabrück GmbH
Osnabrück, , Germany
Helios Kliniken Schwerin GmbH
Schwerin, , Germany
Robert Bosch Gesellschaft für Medizinische Forschung mb
Stuttgart, , Germany
Krankenhaus der Barmherzigen Brüder
Trier, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Katja Sockel, Dr. med.
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Website VEXAS Registry
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VEXAS-Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.